Hot Life Science Investor Mandate 3: European CVC Seeking Point-of-Care Diagnostics

5 Nov

The corporate venture capital arm of a multinational engineering company is headquartered in Germany with offices in Israel and the United States. The firm’s investments are focused on financial returns, as well as, bringing strategic value to the parent company. The firm makes equity investments in seed through growth rounds ranging from €1M-€5M for typical investments and may invest up to €10M-€12M over the life of the investment. The firm will lead, co-lead or follow and typically seeks a 10%-25% stake in the company. The firm is currently investing out of its second fund of €150M with a total of €350M AUM, and makes 4-6 investments per year. The firm focuses on North American, European and Israeli companies.

The firm is only interested in diagnostics and monitoring devices with a particular interest in point-of-care diagnostics. Recent investments include an autonomous, mobile robot with delivery tracking software and a PCR-based diagnostic instrument for rapid pathogen detection. The firm does not invest in traditional biopharma therapeutics and/or medical devices which require FDA approval.

The firm will work with all management teams, including first time entrepreneurs, and requires at least an observatory board seat with most investments requiring a standard board seat with voting rights.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: